[Advancement of treatment for osteoporosis].
Hayashi
Yasufumi
Y
Tokyo Metropolitan Tama Geriatric Hospital.
D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density; D002762:Cholecalciferol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015914:Estrogen Replacement Therapy; D012968:Etidronic Acid / Q000627:therapeutic use; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D010024:Osteoporosis / Q000175:diagnosis / Q000628:therapy*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D024482:Vitamin K 2 / Q000627:therapeutic use
D006887:Hydroxycholecalciferols; D024482:Vitamin K 2; D002762:Cholecalciferol; D020849:Raloxifene Hydrochloride; D012968:Etidronic Acid; C008088:alfacalcidol; D019386:Alendronate